Rui Tan

This inventor holds 12 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 11 EPO patents. Top assignees: Fochon Pharmaceuticals, Ltd., Shanghai Fochon Pharmaceutical Co., Ltd., Chongqing Fochon Pharmaceutical Co., Ltd.. Active years: 2019-2025.

USPTO Granted Patents = 12 (Patent Applications = 6)

% Patents Active = 83.3

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 11.5

ph-index = 1

Forward Citations = 7(Granted Patents)

Company Filing History:

7 out of 7

Fochon Pharmaceuticals, Ltd.

patents

6 out of 13

Shanghai Fochon Pharmaceutical Co., Ltd.

patents

2 out of 3

Chongqing Fochon Pharmaceutical Co., Ltd.

patents

4. 1 out of 3,341

Chinese Academy of Sciences

patents

5. 1 out of 2

Fochon Biosciences, Ltd.

patents

6. 1 out of 1

Fochon Pharmaceutical Co., Ltd.

patent

7. 1 out of 4

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

patents

8. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12394045 - Deep learning based auxiliary diagnosis system for early gastrointestinal cancer and inspection device (2025-08-19),

2. 12312349 - Apoptosis-inducing agents (2025-05-27),

3. 11555042 - Macrocyclic compounds as TRK kinases inhibitors (2023-01-17),

4. 11485707 - Deuterated compounds as rock inhibitors (2022-11-01),

5. 11168078 - Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase (2021-11-09),

6. 11091478 - Apoptosis-inducing agents (2021-08-17),

7. 11053239 - Compounds as BLC-2-selective apoptosis-inducing agents (2021-07-06),

8. 10894038 - Indolizine derivatives, composition and methods of use (2021-01-19),

9. 10835535 - Certain protein kinase inhibitors (2020-11-17),

10. 10800785 - Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitors (2020-10-13),

11. 10450316 - Certain protein kinase inhibitor (2019-10-22),

12. 10328060 - Certain protein kinase inhibitors (2019-06-25),

Title: Inventor Rui Tan: Revolutionizing Technology in Chongqing

Introduction: Rui Tan is a visionary inventor based in Chongqing, China, known for his groundbreaking contributions to the field of technology.

Latest Patents: Rui Tan holds several patents in the areas of artificial intelligence, renewable energy, and smart city solutions, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Rui Tan has worked with leading tech companies in Chongqing, driving research and development initiatives that have led to significant technological advancements.

Collaborations: Throughout his career, Rui Tan has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge sharing.

Conclusion: Rui Tan's passion for innovation and his relentless pursuit of technological excellence continue to inspire the next generation of inventors and shape the future of technology in Chongqing and beyond.